» Articles » PMID: 37624487

Efficacy and Mechanism Study of 6S-5-Methyltetrahydrofolate-Calcium Against Telencephalon Infarction Injury in Zebrafish Model of Ischemic Stroke

Overview
Journal Mol Neurobiol
Date 2023 Aug 25
PMID 37624487
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic stroke is a heterogeneous brain injury with complex pathophysiology and it is also a time sensitive neurological injury disease. At present, the treatment options for ischemic stroke are still limited. 6S-5-methyltetrahydrofolate-calcium (MTHF-Ca) is the calcium salt of the predominant form of dietary folate in circulation. MTHF-Ca has potential neuroprotective effect on neurocytes, but whether it can be used for ischemic stroke treatment remains unknown. We established zebrafish ischemic stroke model through photothrombotic method to evaluate the protective effect of MTHF-Ca on the ischemic brain injury of zebrafish. We demonstrated that MTHF-Ca reduced the brain damage by reducing motor dysfunction and neurobehavioral defects of zebrafish with telencephalon infarction injury. MTHF-Ca counteracted oxidative damages after Tel injury by increasing the activities of GSH-Px and SOD and decreasing the content of MDA. RNA-seq and RT-qPCR results showed that MTHF-Ca played a neuroprotective role by alleviating neuroinflammation, inhibiting blood coagulation, and neuronal apoptosis processes. Overall, we have demonstrated that MTHF-Ca has neuroprotective effect in ischemic stroke and can be used as a potential treatment for ischemic stroke.

Citing Articles

Drug screening for ischemic stroke using larvae and adult zebrafish model: a review.

Nayaka N, Adnyana I, Anggadiredja K, Wibowo I Lab Anim Res. 2025; 41(1):1.

PMID: 39743611 PMC: 11694438. DOI: 10.1186/s42826-024-00232-4.

References
1.
Rodrigo R, Fernandez-Gajardo R, Gutierrez R, Matamala J, Carrasco R, Miranda-Merchak A . Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 2013; 12(5):698-714. DOI: 10.2174/1871527311312050015. View

2.
Besancon E, Guo S, Lok J, Tymianski M, Lo E . Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci. 2008; 29(5):268-75. DOI: 10.1016/j.tips.2008.02.003. View

3.
Xu L, Emery J, Ouyang Y, Voloboueva L, Giffard R . Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia. Glia. 2010; 58(9):1042-9. PMC: 3108566. DOI: 10.1002/glia.20985. View

4.
Wang S, Ma F, Huang L, Zhang Y, Peng Y, Xing C . Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic Stroke. CNS Neurol Disord Drug Targets. 2018; 17(5):338-347. DOI: 10.2174/1871527317666180612125843. View

5.
Zhu X, Xia B, Ye T, Dai M, Yang H, Li C . Ponatinib-induced ischemic stroke in larval zebrafish for drug screening. Eur J Pharmacol. 2020; 889:173292. DOI: 10.1016/j.ejphar.2020.173292. View